Shanghai Fosun Pharmaceutical Group Co. Ltd.
Division of Fosun International Ltd.
www.fosunpharma.com/en
Latest From Shanghai Fosun Pharmaceutical Group Co. Ltd.
Asia Deal Watch: Fujifilm Affiliate Out-Licenses Antifungal Candidate To Canada’s Appili
Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.
Global Top Three Trade Places As Going Gets Tough, Especially In The US
Mylan has moved up to become the world’s leading generics, biosimilars and OTC player, according to Generics Bulletin’s newly compiled global rankings. Sandoz has surpassed troubled Teva into second spot, but is set to surrender that position once it sells its US solid-dose and dermatology business to India’s Aurobindo, which has already moved into the global top 10.
International Demand For Robotic Surgery Drives Intuitive Surgical’s Revenues Up 21% in Q2
Intuitive Surgical reported on 18 July that worldwide da Vinci procedures were up about 17% in the second quarter of 2019 compared to the same period of 2018. While the US still accounts for the majority of Intuitive’s revenue, procedure volume outside the US is growing faster, especially in Asia.
Double Approval Boost For Dova’s Doptelet But EU Licensee Still Sought
A first approval in the EU and an expanded US label for Dova’s TPO product should alter the its sales trajectory – all it needs now is an EU partner.
Company Information
- Industry
- Distributors
- In Vitro Diagnostics
- Medical Devices
-
Pharmaceuticals
- Vaccines
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gastrointestinal
- Infectious & Viral Diseases
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Asia
-
China
-
China
-
Asia
- Parent & Subsidiaries
-
Fosun International Ltd.
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Breas Medical AB
- Chongqing Fochon Pharmaceutical Research Co. Ltd.
- Hunan Dongting Pharmaceutical Co. Ltd.
- Jiangsu Wanbang Biochemical Pharmaceutical Group
- Jinzhou Ahon Pharmaceutical Co Ltd.
- Shanghai Chemo Wanbang Biopharma Co. Ltd.
- Shanghai Fosun Long March Medical Science Co. Ltd.
- Suzhou Erye Pharmaceutical Co. Ltd.
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Senior Management
-
Wu Yifang, Pres. & CEO
Guan Xiaohui, SVP, CFO
Shao Ying, VP, Dir, R&D - Contact Info
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
Phone: (86) 21 33987000
1289 Yishan Rd.
Bldg. A
Shanghai , 200233
China
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice